The gap between Nifty's price-earnings multiple and economic growth is at a 12-year high
Increased price control over branded generic medicines has affected its profitability
One thing has remained constant through the Indian economy in the last seven decades: the dominance of family-owned businesses. Krishna Kant reports.
Bombay House will be closed for renovation - its first such closure in 93 years
Indian Hotels rolls back its multi-brand strategy to focus solely on luxury, looks to paint all its properties with the Tajness brush.
12 out of 21 public sector banks reported declines in their loan books in the last financial year against seven such banks in 2015-16 and none in 2013-14.
Fresh investments by corporates up just 5.8% in FY17, lowest since 1992
'Younger people are taking steps to prevent lifestyle diseases.'
'It is fascinating to partner with consumers on the journey of self-discovery and to help shape people's preferences -- that is what I find most exciting,' Nandini Piramal tells Abhineet Kumar and Aneesh Phadnis.
Once tipped to emerge as the biggest exporter, the pharmaceutical industry is yet to acquire the scale of those in software services, says Krishna Kant.
The commercial vehicle business is one of the mainstays for the Tata group, highlighting the importance of Girish Wagh's appointment.
Invests $1.1 billion in 6 months, against $3.7 billion in 20 years
'And the top 10 per cent will grow because they have to serve the market.'
Tata Communications has elected the private equity (PE) veteran as a successor to Subodh Bhargava.
He's betting big on small stores to help him reach 10 million households by FY21, report Abhineet Kumar and Raghavendra Kamath.
While UltraTech Cement has been the biggest value creator adding nearly Rs 99,000 crore to its market capitalisation, Grasim Industries has added around Rs 27,000 crore to its market cap.
At Rs 470,000 for the base petrol variant, Tigor is now the cheapest compact sedan in the country
Wonder why corporate India is showering dividends?
The Essar Oil, Rosneft deal also helped Arpwood Capital, boutique investment bank, co-founded by Rajeev Gupta and Raj Kataria, to grab the second spot in the mergers and acquisitions league table.
Sun Pharmaceutical, which is growing its dermatology and ophthalmic specialty business in the US will spend $460 million on R&D.
Indian companies have made acquisitions of $1 billion so far in January
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances